Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
Mezzaroma
I
I
Giovannetti
A
A
Pinter
E
E
Ensoli
F
F
Aiuti
F
F
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000517:prevention & control; D000328:Adult; D019380:Anti-HIV Agents / Q000276:immunology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000517:prevention & control
D019380:Anti-HIV Agents